Skip to main content
. 2022 Apr 29;23(6):191. doi: 10.3892/ol.2022.13311

Table I.

Frequently used immune checkpoint inhibitors and their molecular targets.

Molecular target Generic drug name Brand name
PD-1 Pembrolizumab Keytruda
Nivolumab Opdivo
PD-L1 Atezolizumab Tecentriq
Durvalumab Imfinzi
Avelumab Bavencio
CTLA-4 Ipilimumab Yervoy

PD-1, programmed cell death-1; PD-L1, programmed cell death-ligand 1; CTLA-4, cytotoxic T-lymphocyte-associated protein-4.